Sage Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $180k | 33k | 5.43 |
| 2024-09-30 | $188k | 26k | 7.22 |
| 2024-06-30 | $268k | 25k | 10.86 |
| 2024-03-31 | $325k | 17k | 18.74 |
| 2023-12-31 | $345k | 16k | 21.67 |
| 2023-09-30 | $1.8M | 88k | 20.58 |
| 2023-06-30 | $2.6M | 54k | 47.02 |
| 2022-12-31 | $371k | 9.7k | 38.14 |
| 2022-09-30 | $462k | 12k | 37.31 |
| 2022-06-30 | $83k | 2.6k | 32.07 |
| 2022-03-31 | $60k | 1.6k | 38.46 |
| 2021-12-31 | $48k | 1.2k | 38.46 |
| 2021-09-30 | $3.3M | 74k | 44.25 |
| 2021-06-30 | $7.1M | 124k | 56.82 |
| 2021-03-31 | $7.8M | 104k | 74.85 |
| 2020-12-31 | $9.1M | 106k | 86.52 |
| 2020-09-30 | $20M | 334k | 61.12 |
| 2020-06-30 | $10M | 250k | 41.58 |
| 2020-03-31 | $3.3M | 116k | 28.72 |
| 2019-12-31 | $6.0M | 84k | 72.20 |
| 2019-09-30 | $62M | 440k | 140.29 |
| 2019-06-30 | $73M | 399k | 183.09 |
| 2019-03-31 | $59M | 371k | 159.05 |
| 2018-12-31 | $30M | 311k | 95.79 |
| 2018-09-30 | $55M | 389k | 141.25 |
| 2018-06-30 | $44M | 280k | 156.53 |
| 2018-03-31 | $28M | 176k | 161.07 |
| 2017-12-31 | $5.1M | 31k | 164.71 |
| 2017-06-30 | $6.0M | 75k | 79.65 |
| 2017-03-31 | $2.4M | 34k | 71.08 |
| 2016-12-31 | $1.9M | 38k | 51.07 |
| 2016-09-30 | $982k | 21k | 46.00 |
| 2016-06-30 | $822k | 27k | 30.14 |
| 2016-03-31 | $814k | 25k | 32.06 |
| 2015-12-31 | $1.4M | 25k | 58.29 |
| 2015-09-30 | $646k | 15k | 42.33 |
| 2015-03-31 | $82k | 1.6k | 50.30 |
| 2014-12-31 | $10k | 267 | 37.45 |